Inivata Insights
Keep up to date with our latest conversations, discussions and stories – together we can transform clinical cancer care
2022 ASCO® Annual Meeting: Highlights and observations
Event expiration date display - 14 JULY 2022
Our Director of Clinical & Scientific Alliances, Mike Nahorski discusses his highlights from the 2022 ASCO® Annual Meeting. read more
Building on strong foundations
Event expiration date display - 27 JUNE 2022
Our CMO, David Eberhard, reflects on ASCO 2022, discussing what attracted him to Inivata, and where the company fits in the molecular diagnostics market. read more
Getting to Know Meadow Stokes, Head of Program Management
Event expiration date display - 21 JUNE 2022
Meadow Stokes recently joined #TeamInivata as our new Head of Program Management in our Program Management Office. In our latest blog, Meadow talks about her journey into PMO and why she decided to join Inivata. read more
Getting to know Ciara Airey, Head of Regulatory Affairs
Event expiration date display - 24 MAY 2022
Hear from our latest member of #TeamInivata, Ciara Airey as she discusses her work experience prior to working at Inivata, the biggest achievements and challenges of her career so far, and what made her join Inivata. read more
Getting to know Pamela Brooks, Senior Patent Paralegal
Event expiration date display - 20 APR 2022
#TeamInivata welcomes a new member. We spoke to Pamela Brooke, Senior Patent Paralegal in our Product Development department. In our latest blog, Pamela discusses her experience prior to joining Inivata, what made her want to work in the field of liquid biopsy and the biggest achievements and challenges of her career so far. read more
Getting to know Kiran Alyshah, QA Specialist
Event expiration date display - 29 MAR 2022
As #TeamInivata continues to grow, we spoke to Kiran, our new QA Specialist in the Global Operations Department, about her journey into science and why she decided to join the company. read more
The role of cell-free circulating tumor DNA (ctDNA) for detection of minimal residual disease (MRD) and recurrence in head and neck cancer
Event expiration date display - 24 FEB 2022
Karen Howarth, PhD, Senior Director of Clinical Genomics, Inivata read more
2021 San Antonio Breast Cancer Symposium (SABCS): Highlights and Observations
Event expiration date display - 26 JAN 2022
Adalynn Harris, Oncology Medical Science Liaison and Dr Mike Nahorski, Director of Clinical and Scientific Alliances read more
Getting to know Bev Monahan, BioPharma Business Development team
Event expiration date display - 07 DEC 2021
My career in healthcare spans more than 25 years, during which time I have been mainly focused on cancer diagnostics and biotech. read more
Sasha’s Story
Event expiration date display - 12 NOV 2021
Inivata’s test has potentially bought me several more years that I wouldn’t have had otherwise. That’s something that money can’t buy. read more
2021 World Conference on Lung Cancer: Highlights and Thoughts
Event expiration date display - 08 NOV 2021
Adalynn Harris, PhD, MPH, MHA read more
Liquid biopsy highlights from the ESMO 2021 virtual congress
Event expiration date display - 12 OCT 2021
Dr Mike Nahorski, Director of Clinical and Scientific Alliances provides a perspective of ESMO2021. read more
ASCO2021 Highlights – Focus on Liquid Biopsy
Event expiration date display - 28 Jun 2021
Dr Mike Nahorski who recently joined Inivata as Director, Clinical and Scientific Alliances summarizes the key liquid biopsy highlights at ASCO2021. read more
AACR Annual Meeting 2021 – An overview
Event expiration date display - 13 MAY 2021
Greg Jones our Sr Director, Medical Affairs provides an overview of the growing evidence for ctDNA changing how we detect residual disease and recurrence read more
Motivated by a meaningful purpose: Tim Forshew, Co-founder and Head of Science and Innovation, Inivata
Event expiration date display - 26 APR 2021
Tim talks us through the founding of Inivata and how Nitzan Rosenfeld inspired him to join the team. read more
Product Development from the eyes of an R&D Scientist
Event expiration date display - 23 APR 2021
Creative and bold individuals make up Inivata. Garima Sharma shares her insights into RaDaR development and how the team have worked together to build an industry-leading liquid biopsy test. read more
LBx Summit 2021 review and thoughts
Event expiration date display - 23 FEB 2021
Yanin Naiyachit, Product Manager – Liquid Biopsy Applications here at Inivata, shares his thoughts and key take-aways from the recent LBx Summit 2021. read more
Alan Schafer our new CTO discusses the potential of personalized liquid biopsy in clinical trial development and recruitment
Event expiration date display - 11 NOV 2020
Find out more about the potential of personalized liquid biopsy in clinical trial development and recruitment read more
“Liquid biopsy: a key piece in the diagnostic jigsaw puzzle” by Peter Collins, Chief Business Officer, Inivata
Event expiration date display - 11 NOV 2020
We recently welcomed Peter Collins to Inivata as our new CBO, find out more here read more
Sarah Perrey DeGeare in our Lab Operations team talks about what it’s like to be part of #TeamInivata
Event expiration date display - 09 NOV 2020
Find out what it is like to be part of our team. read more
The start of Lung Cancer Awareness Month 2020
Event expiration date display - 01 NOV 2020
Today marks the start of Lung Cancer Awareness Month, a critical point in time for all those working on any aspect of this devastating disease to stop, think and remind ourselves why we’re doing what we’re doing. read more
Jenni Westoby joined our Bioinformatics Team eight months ago and is really enjoying being part of the team.
Event expiration date display - 21 JUL 2020
Find out more about her first few months with us. read more
AACR 2020 Summary: Demonstrating a sensitive and specific personalized assay to detect residual disease and recurrence
Event expiration date display - 07 JUL 2020
This year’s annual meeting of the American Association for Cancer Research (AACR) was converted into an entirely virtual experience focused on clinical data as a result of the COVID-19 pandemic. For Inivata, this meant that we were still able to present two posters sharing exciting provisional data around our recently launched personalized RaDaRTM assay. read more
Sophie Hackinger in our bioinformatics team discusses the reasons she joined Inivata – I wanted to build products that would have a direct impact on patients’ lives.
Event expiration date display - 20 APR 2020
I started out with an undergraduate degree in biomedical sciences, which was more wet lab focused. What really fascinated me about human biology was how the combination of multiple genetic and environmental factors interact to influence phenotypic traits. This is what ultimately attracted me to the field of complex disease genetics. read more
The development of a highly sensitive test for detecting residual disease and recurrence in cancer patients
Event expiration date display - 21 JUL 2020
As cells die in our body, they release DNA into our blood stream. This cell free DNA (cfDNA) can come from many sources, including healthy cells such as white blood cells. In individuals with cancer, DNA from the tumor, known as circulating tumor DNA (ctDNA), will also be present in the bloodstream. read more
Anna Farne, Senior Software Developer at Inivata tells us more about how her role in software development is helping transforming the lives of cancer patients around the world.
Event expiration date display - 7 APR 2020
During my first role working as a lab technician I became interested in IT and how it fits into a science and research environment. There were nice software tools for data analysis, LIMS systems for tracking samples through the lab and robots that needed programming. read more
Tim Forshew, Co-founder and Head of Science and Innovation at Inivata shares his thoughts on a recent publication from groups at Dana-Farber, Broad Institute and Boston University that demonstrate the value of personalized assays for detecting ctDNA with high sensitivity.
Event expiration date display - 1 APR 2020
Thoughts on Parsons et al 2020 – a new study on the value of personalized ctDNA assays for residual disease and recurrence detection read more
Warren Emmett, Computational Genomics Team Lead at Inivata talks about how his role in bioinformatics is helping lung cancer patients.
Event expiration date display - 04 MAR 2020
I started out with an undergrad in Human Genetics and after doing a tutorial on the BLAST algorithm I fell in love with bioinformatics, and the potential it held for changing biology. After completing my masters in Bioinformatics, I was offered an opportunity read more
The critical importance of sensitivity and how inivata’s technology is expanding the reach of liquid biopsy into new clinical and pharmaceutical applications.
Event expiration date display - 28 JAN 2020
Antony Newton, VP Business Development, talks about the critical importance of sensitivity and how Inivata’s technology is expanding the reach of liquid biopsy into new clinical and pharmaceutical applications. read more
Pioneering and focused on making a difference to cancer management – liquid biopsy.
Event expiration date display - 13 NOV 2019
Liquid biopsy offers the potential to transform the way physicians manage cancer and deliver significant benefits to patients by guiding and personalizing treatment, monitoring response and detecting relapse. read more
A personal passion for innovation and to make a difference to cancer care.
Event expiration date display - 31 OCT 2019
Nitzan Rosenfeld, CSO and Co-founder, Inivata talks about the personal story behind his scientific career and his path to making fundamental breakthroughs in liquid biopsyWhat drove you towards ... read more
